Citi lowered the firm’s price target on Bath & Body Works to $36 from $48 and keeps a Buy rating on the shares after meeting with management. Given the uncertainty, the company provided few details around the impact of higher tariffs, the analyst tells investors in a research note. The firm says Bath & Body is doing more work regarding how much of its 80% domestic sourcing may be exposed to inputs sourced abroad. Citi cut estimates to account for the impact of higher tariffs and a weakening consumer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Softlines partially priced in China tariffs, not Vietnam, says Morgan Stanley
- Bath & Body Works files automatic mixed securities shelf
- Positive Outlook for Bath & Body Works Driven by Innovation and Strategic Growth Initiatives
- Bath & Body Works Reaffirms 2025 Financial Guidance
- Bath & Body Works backs Q1 EPS view of 36c-43c, consensus 42c